Nexus Biopharma, Inc. is a preclinical stage biotechnology company, which engages in the research and development of new therapies and intellectual property for treating obesity and type 2 diabetes. The company was founded by Warren C. Lau on July 17, 2007 and is headquartered in Houston. TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Nexus Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nexus Biopharma Inc market cap is $662,300.00.
What is the 52-week high for Nexus Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nexus Biopharma Inc 52 week high is $0.50 as of September 26, 2025.
What is the 52-week low for Nexus Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nexus Biopharma Inc 52 week low is $0.00 as of September 26, 2025.
What is Nexus Biopharma Inc stock price today?
Nexus Biopharma Inc stock price today is $0.0103.
What was Nexus Biopharma Inc stock price yesterday?
Nexus Biopharma Inc stock price yesterday was $0.000001.
What is the 50-day moving average of Nexus Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nexus Biopharma Inc 50-day moving average is $0.0107.